Development and validation of an imageless machine-learning algorithm for the initial screening of prostate cancer.

Journal: The Prostate
PMID:

Abstract

PURPOSE: Prostate specific antigen (PSA) testing is a low-cost screening method for prostate cancer (PCa). However, its accuracy is limited. While progress is being made using medical imaging for PCa screening, PSA testing can still be improved as an easily accessible first step in the screening process. We aimed to develop and validate a new model by further personalizing the analysis of PSA with demographic, medical history, lifestyle parameters, and digital rectal examination (DRE) results.

Authors

  • Nicolas Martelin
    Prostperia, Nancy, France.
  • Brian De Witt
    Prostperia, Nancy, France.
  • Benjamin Chen
    Prostperia, Nancy, France.
  • Pascal Eschwège
    Service d'Urologie CHRU Nancy, Site Brabois, Nancy, 54000, France.